EU Regulators Take A Practical Approach To Addressing Nitrosamine Contamination

 
• By Vibha Sharma

Regulators in the EU have decided on specific arrangements they plan to employ if sponsors detect and report nitrosamine impurities in their products being sold on the market.

Medic staff at work in the laboratory. Background
Chemical and biological drug sponsors must review their products for possible presence of nitrosamines • Source: Shutterstock

More from Manufacturing

More from Compliance